Specialty
Nephrology devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
220
510(k), De Novo and PMA
Decisions, last 36 months
63
Recruiting device trials
36
Industry sponsored
Adverse event reports
9,177
Received Nov 1, 2025 to Nov 19, 2026
Part of
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
- multiFiltratePRO System510(k)
Fresenius Medical Care Renal Therapies Group, LLC
K261203 · Decided Oct 19, 2026 · 189 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
Nipro Technical Solutions, Incoporated
K260799 · Decided Aug 19, 2026 · 161 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
- ELISIO-HX510(k)
K261399 · Decided Jul 28, 2026 · 90 days after receipt
Device type: Hemodialyzer With Expanded Solute Removal Profile (QAX) · GI, Urology & Nephrology
Fresenius Medical Care Renal Therapies Group, LLC
K261267 · Decided Jul 24, 2026 · 99 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
- Perfadex Plus510(k)
K261644 · Decided Jul 23, 2026 · 66 days after receipt
Device type: System, Perfusion, Kidney (KDN) · GI, Urology & Nephrology
K260456 · Decided Jun 1, 2026 · 110 days after receipt
Device type: System, Perfusion, Kidney (KDN) · GI, Urology & Nephrology
Fresenius Medical Care Renal Therapies Group, LLC
K252377 · Decided May 15, 2026 · 289 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
- ELISIO-H510(k)
K260533 · Decided Mar 19, 2026 · 30 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 5 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 |
| Mar 24 | 2 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 |
| May 24 | 3 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 |
| Jul 24 | 2 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 |
| Nov 24 | 2 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 |
| Jan 25 | 2 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 |
| Mar 25 | 3 | 0 | 0 |
| Apr 25 | 5 | 0 | 0 |
| May 25 | 8 | 0 | 0 |
| Jun 25 | 2 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 |
| Aug 25 | 3 | 0 | 0 |
| Sep 25 | 2 | 0 | 0 |
| Oct 25 | 2 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 |
| Dec 25 | 1 | 0 | 0 |
| Jan 26 | 3 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 |
| May 26 | 1 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 |
| Jul 26 | 3 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 |
| Oct 26 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
- Post Market Study for VasQ, an External Support Implant for Arteriovenous FistulaPivotal-lookingRecruiting
Laminate Medical TechnologiesNot on our public-company list
NCT06516653 · 300 participants (planned) · Start Jan 13, 2025 · Primary completion Aug 2027
Device: VasQ · For: End Stage Renal Disease
Sites: Long Beach, California; Sarasota, Florida; Atlanta, Georgia · 13 sites in all
Calyxo, Inc.Not on our public-company list
NCT07155005 · 1,000 participants (planned) · Start Oct 12, 2026 · Primary completion Dec 2028
Device: CVAC® SYSTEM; FLEXIBLE AND NAVIGATIONAL URETERAL ACCESS SHEATH (FANS) IN FLEXIBLE URETEROSCOPY (FURS) and 1 more · For: Urolithiasis; Stones, Kidney; Renal Stones and 1 more
Sites: Miami, Florida; Wichita, Kansas; Cheektowaga, New York · 10 sites in all
- Maturation of Arteriovenous Fistula With Automated Sonography Assessments TrialPivotal-lookingRecruiting
Sonavex, Inc.Not on our public-company list
NCT06190717 · 304 participants (planned) · Start Feb 21, 2024 · Primary completion Feb 1, 2028
Device: EchoMark/EchoSure · For: Diabetes; End Stage Renal Disease
Sites: Dothan, Alabama; Phoenix, Arizona; Tucson, Arizona · 23 sites in all
- Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration TechnologyPivotal-lookingRecruiting
Calyxo, Inc.Not on our public-company list
NCT07101809 · 150 participants (planned) · Start May 21, 2026 · Primary completion Jul 2027
Device: Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System; Standard Ureteroscopy (URS) · For: Urolithiasis; Stones, Kidney; Renal Stones and 1 more
Sites: Birmingham, Alabama; Gainesville, Florida; New York, New York · 6 sites in all
- Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney InjuryPivotal-lookingRecruiting
SeaStar MedicalNot on our public-company list
NCT05758077 · 339 participants (planned) · Start Apr 17, 2023 · Primary completion Dec 2026
Device: Selective Cytopheretic Device · For: Acute Kidney Injury
Sites: Birmingham, Alabama; Phoenix, Arizona; Los Angeles, California · 36 sites in all
Medtronic VascularPublic (MDT)
NCT07115953 · 130 participants (planned) · Start Sep 22, 2025 · Primary completion Oct 30, 2027
Device: Symplicity Spyral™ multi-electrode renal denervation system · For: Hypertension; Vascular Diseases; Cardiovascular Diseases and 2 more
Sites: Melbourne, Australia; Perth, Australia; Genk, Belgium · 21 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
9,177
Received Nov 1, 2025 to Nov 19, 2026. Includes 86 of another or unstated type.
Malfunction reports
5,881
64% of reports
Injury reports
3,021
33% of reports
Death reports
189
2.1% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 498 | 225 | 7 | 1 |
| Dec 25 | 501 | 280 | 15 | 1 |
| Jan 26 | 483 | 250 | 20 | 0 |
| Feb 26 | 555 | 227 | 14 | 0 |
| Mar 26 | 593 | 238 | 14 | 0 |
| Apr 26 | 660 | 218 | 10 | 0 |
| May 26 | 420 | 247 | 23 | 0 |
| Jun 26 | 415 | 267 | 16 | 0 |
| Jul 26 | 479 | 268 | 7 | 4 |
| Aug 26 | 454 | 260 | 14 | 30 |
| Sep 26 | 410 | 274 | 28 | 44 |
| Oct 26 | 413 | 267 | 21 | 6 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2984-2026 · Started Aug 10, 2026 · Posted by FDA Sep 11, 2026
Reason given: this is a downstream recall of class I recall RES 98777
Cause as FDA categorized it: Material/Component Contamination · Device type: Catheter, Hemodialysis, Non-Implanted (MPB)
Z-2985-2026 · Started Aug 10, 2026 · Posted by FDA Sep 11, 2026
Reason given: this is a downstream recall of class I recall RES 98777
Cause as FDA categorized it: Material/Component Contamination · Device type: Catheter, Hemodialysis, Non-Implanted (MPB)
Fresenius Medical Care Renal Therapies Group, LLC
Z-3084-2026 · Started Aug 10, 2026 · Posted by FDA Sep 2, 2026
Reason given: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
Cause as FDA categorized it: Component change control · Device type: Accessories, Blood Circuit, Hemodialysis (KOC)
- 5008X HD/HDF Standard Blood Tubing Set Part Number 03-5300-3Open, Classified
Fresenius Medical Care Renal Therapies Group, LLC
Z-3085-2026 · Started Aug 10, 2026 · Posted by FDA Sep 2, 2026
Reason given: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
Cause as FDA categorized it: Component change control · Device type: Accessories, Blood Circuit, Hemodialysis (KOC)
- 5008X HD/HDF with CLiC Blood Tubing Set Part number 03-5300-3COpen, Classified
Fresenius Medical Care Renal Therapies Group, LLC
Z-3086-2026 · Started Aug 10, 2026 · Posted by FDA Sep 2, 2026
Reason given: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
Cause as FDA categorized it: Component change control · Device type: Accessories, Blood Circuit, Hemodialysis (KOC)
- 5008X HD/HDF with Twister Blood Tubing Set Part Number 03-5350-8Open, Classified
Fresenius Medical Care Renal Therapies Group, LLC
Z-3087-2026 · Started Aug 10, 2026 · Posted by FDA Sep 2, 2026
Reason given: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
Cause as FDA categorized it: Component change control · Device type: Accessories, Blood Circuit, Hemodialysis (KOC)
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201Open, Classified
Nipro Renal Soultions USA, Corporation
Z-3133-2026 · Started Aug 5, 2026 · Posted by FDA Sep 10, 2026
Reason given: Hemodialysis concentrates contain high endotoxin levels
Cause as FDA categorized it: Process control · Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO)
- MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))Open, Classified
Nipro Renal Soultions USA, Corporation
Z-3134-2026 · Started Aug 5, 2026 · Posted by FDA Sep 10, 2026
Reason given: Hemodialysis concentrates contain high endotoxin levels
Cause as FDA categorized it: Process control · Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO)
Showing the 8 newest of 935 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.